Page last updated: 2024-09-04

2'-fluorothymidine and Lung Neoplasms

2'-fluorothymidine has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alauddin, MM; Bornmann, W; Gelovani, JG; Mawlawi, O; Mukhopadhyay, U; Nishii, R; Pal, A; Volgin, AY	1
Burchenal, JH; Fanucchi, MP; Fox, JJ; Leyland-Jones, B; Watanabe, KA; Young, CW	1

Other Studies

2 other study(ies) available for 2'-fluorothymidine and Lung Neoplasms

Article	Year
Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT. European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:5 Topics: Animals; Arabinofuranosyluracil; Cell Proliferation; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2008
Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU). Cancer treatment reports, 1985, Volume: 69, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Central Nervous System Diseases; Drug Evaluation; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Platelet Count; Uridine; Vomiting	1985

Article

Year

Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.

European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:5

Topics: Animals; Arabinofuranosyluracil; Cell Proliferation; Dideoxynucleosides; Fluorine Radioisotopes; Humans; Lung Neoplasms; Mice; Mice, Nude; Neoplasm Invasiveness; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2008

Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU).

Cancer treatment reports, 1985, Volume: 69, Issue:1

Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Central Nervous System Diseases; Drug Evaluation; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Platelet Count; Uridine; Vomiting

1985